Cargando…

Anthracycline‑induced delayed‑onset cardiac toxicity: A case report and literature review

Anthracyclic (ANT) drugs are widely used for patients with malignant tumors and can markedly prolong the disease-free survival rate of patients. As its clinical application becomes more common, information regarding serious cardiotoxicity as a result of ANT treatment is becoming understood. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Mowei, Pan, Qiongxiang, Cheng, Xunmin, Li, Jun, Gao, Yu, Tian, Xue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562964/ https://www.ncbi.nlm.nih.gov/pubmed/37822590 http://dx.doi.org/10.3892/etm.2023.12204

Ejemplares similares

Selenium in the Prevention of Anthracycline-Induced Cardiac Toxicity in Children with Cancer
por: Tacyildiz, Nurdan, et al.
Publicado: (2012)

Comparative Cardiac Toxicity of Anthracyclines In Vitro and In Vivo in the Mouse
por: Toldo, Stefano, et al.
Publicado: (2013)

Cardiac Toxicity and Anthracyclines: Mechanism, Interventions, and the Trouble With Troponin
por: Thompson, Grace E., et al.
Publicado: (2019)

Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
por: Liu, Jing, et al.
Publicado: (2022)

A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity
por: Yang, Xinyu, et al.
Publicado: (2018)

Radiotherapy and anthracyclines – cardiovascular toxicity
por: Mozdzanowska, Dagmara, et al.
Publicado: (2014)

Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
por: Huelsenbeck, J, et al.
Publicado: (2011)

Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents
por: Seemann, Ingar, et al.
Publicado: (2013)

Novel Mechanisms of Anthracycline-Induced Cardiovascular Toxicity: A Focus on Thrombosis, Cardiac Atrophy, and Programmed Cell Death
por: Antoniak, Silvio, et al.
Publicado: (2022)

Anthracycline-induced toxicity affecting palmar and plantar skin.
por: Jones, A. P., et al.
Publicado: (1989)

Anthracycline-induced cardiotoxicity: A case report and review of literature
por: Chong, Esther G, et al.
Publicado: (2021)

Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
por: Vavrova, Anna, et al.
Publicado: (2013)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

High anthracycline cumulative dose without cardiac toxicity: A possible protective role of morphine
por: Canale, Maria Laura, et al.
Publicado: (2018)

Case report: Uridine triacetate in the management of delayed onset 5-fluorouracil toxicity: A case report and review of literature
por: Jacob, Aasems, et al.
Publicado: (2022)

Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials
por: Attar, Armin, et al.
Publicado: (2022)

Toxicity, outcome, and management of anthracycline overdoses in 16 dogs
por: Lawson, Haylie C., et al.
Publicado: (2021)

Delayed Onset Anthracycline-Associated Cardiotoxicity Presenting as Acute Decompensated Heart Failure Seven Years After Chemotherapy Completion
por: Tran, Dan B, et al.
Publicado: (2021)

RBL2 Regulates Cardiac Sensitivity to Anthracycline Chemotherapy
por: Xia, Peng, et al.
Publicado: (2023)

Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation
por: Rahman, Atiar M, et al.
Publicado: (2007)

Cardiac magnetic resonance characteristics of acute anthracycline-induced cardiotoxicity
por: Toro-Salazar, Olga H, et al.
Publicado: (2016)

Characterisation of the long-term effects of anthracycline-associated myocardial toxicity using cardiac MRI; a pilot study
por: Hughes, Marina L, et al.
Publicado: (2009)

Changes in ischemia-modified albumin in myocardial toxicity induced by anthracycline and docetaxel chemotherapy
por: Luan, Xiao-Dong, et al.
Publicado: (2017)

Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity
por: Mahjoob, Mohammad P., et al.
Publicado: (2020)

Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity
por: Feher, Attila, et al.
Publicado: (2022)

Fatal butane toxicity and delayed onset of refractory ventricular fibrillation
por: Almulhim, Khalid N.
Publicado: (2017)

Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
por: Vuong, Jacqueline T., et al.
Publicado: (2022)

Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy
por: Hung, Olivia Y, et al.
Publicado: (2015)

The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
por: Ayuna, Ahmed, et al.
Publicado: (2020)

Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion
por: Kaskinen, Anu K., et al.
Publicado: (2021)

Efficacy of Dexrazoxane in Cardiac Protection in Pediatric Patients Treated With Anthracyclines
por: Rahimi, Parya, et al.
Publicado: (2023)

Sildenafil for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: A Phase I/II Randomized Clinical Trial, SILDAT-TAHA6 Trial
por: Attar, Armin, et al.
Publicado: (2022)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Anthracycline-induced cardiotoxicity and senescence
por: Booth, Laura K., et al.
Publicado: (2022)

Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study
por: Linares Ballesteros, Adriana, et al.
Publicado: (2021)

Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
por: Blaes, Anne H, et al.
Publicado: (2015)

Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study
por: Narayan, Hari K, et al.
Publicado: (2017)

Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
por: Egashira, Koichi, et al.
Publicado: (2021)

Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
por: Rafiyath, Shamudheen M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mr2q76oj4doead0jpdac02m4f1